Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Filings indexed 1,621 across all filing types
Latest filing 2023-08-16 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
独立董事关于第四届董事会第十六次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on specific board meeting proposals, including the use of idle raised funds and extension of authorization related to a 2022 private placement of A shares. It references compliance with laws and company rules but does not contain financial statements or detailed financial data. The document is a formal opinion related to board decisions rather than a full report or announcement of voting results. It is not a full Annual Report, Interim Report, or Earnings Release. It is also not a regulatory filing or certification letter. The content fits best under Board/Management Information (MANG) as it relates to board meeting matters and management decisions.
2023-08-16 Chinese
关于延长公司向特定对象发行A股股票股东大会决议有效期及授权有效期的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the company regarding the extension of the validity period of a shareholder meeting resolution and authorization related to a specific issuance of A shares to certain investors. It discusses board and supervisory meetings, shareholder meeting approvals, regulatory approval from the China Securities Regulatory Commission, and the extension of the authorization period. The document does not contain financial statements or detailed financial data but is a formal announcement about corporate governance and shareholder meeting resolutions related to capital issuance. This fits the category of Capital/Financing Update (CAP), as it concerns updates on company fundraising and capital structure changes.
2023-08-16 Chinese
中德证券有限责任公司关于天域生态环境股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见
Regulatory Filings
2023-08-16 Chinese
关于归还募集资金及继续使用部分闲置募集资金暂时补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Tianyu Ecological Environment Co., Ltd. regarding the continued use of idle raised funds to temporarily supplement working capital. It details the approval by the board of directors, the amount of funds involved, the regulatory approvals, and the compliance with relevant regulations. The document does not contain financial statements or detailed financial analysis but rather focuses on the use and management of raised funds. It is a regulatory announcement about capital usage rather than a full financial report or audit. The document length is 3311 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP).
2023-08-16 Chinese
关于召开2023年第四次临时股东大会的通知
Regulatory Filings Classification · 95% confidence The document is a notice about convening the 2023 fourth extraordinary general meeting of shareholders, including details about the meeting date, voting methods, agenda items, and instructions for shareholders. It does not contain financial statements or detailed financial analysis. The document is primarily an announcement of a shareholder meeting and related procedural information, not a report or results announcement. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself and voting procedures rather than solicitation materials, it is best classified as a Regulatory Filing (RNS) as a fallback for general regulatory announcements that do not fit other categories. The document length is under 5,000 characters and is a formal announcement, not a report or transcript. Hence, the best classification is Regulatory Filings (RNS).
2023-08-16 Chinese
2023年第四次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2023 年第四次临时股东大会会议资料' which translates to '2023 Fourth Extraordinary General Meeting (EGM) Materials'. It contains detailed meeting agenda, voting procedures, and proposals to be discussed and voted on at the shareholders meeting. The content includes meeting notices, agenda items, and proposals for shareholder approval, which are typical of materials distributed to shareholders before or during a general meeting. There is no indication that this is a report of voting results or a summary of the meeting outcome, nor is it a full annual or interim financial report. The document is not a proxy solicitation or remuneration report. It is clearly the meeting materials provided for the shareholders to review and prepare for the meeting. Therefore, this document fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting.
2023-08-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.